Hunan Fangsheng Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001VG6
CNY
11.44
0.2 (1.78%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,746.51
1,599.27
1,763.45
1,542.64
1,259.35
1,072.81
1,029.51
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,746.51
1,599.27
1,763.45
1,542.64
1,259.35
1,072.81
1,029.51
Raw Material Cost
548.67
568.97
641.30
621.26
511.72
331.81
299.39
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
22.12
21.46
24.84
18.85
17.29
11.22
5.63
Selling and Distribution Expenses
821.71
775.59
920.70
751.83
608.05
621.67
598.47
Other Expenses
10.10
7.08
3.47
2.64
3.05
2.62
3.30
Total Expenditure (Excl Depreciation)
1,493.53
1,436.86
1,621.54
1,418.30
1,167.60
990.92
936.51
Operating Profit (PBDIT) excl Other Income
253
162.39999999999998
141.9
124.3
91.8
81.89999999999999
93
Other Income
85.30
69.32
215.27
0.91
20.79
39.66
19.44
Operating Profit (PBDIT)
409.35
312.47
444.12
214.83
191.49
177.87
155.66
Interest
22.12
21.46
24.84
18.85
17.29
11.22
5.63
Exceptional Items
-11.52
-2.38
0.19
-14.01
-6.06
-7.18
0.00
Gross Profit (PBDT)
1,197.85
1,030.30
1,122.15
921.39
747.63
741.00
730.12
Depreciation
84.85
81.11
88.12
89.72
79.68
56.50
44.91
Profit Before Tax
290.86
207.52
331.35
92.25
88.46
102.96
105.12
Tax
36.14
23.71
49.87
20.87
15.20
15.50
12.38
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
255.22
186.82
285.85
70.04
63.79
78.91
72.99
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
255.22
186.82
285.85
70.04
63.79
78.91
72.99
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-5.37
-7.20
-9.15
-0.12
-10.02
0.06
6.81
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
249.85
179.62
276.71
69.92
53.78
78.97
79.81
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,622.97
1,458.09
1,390.12
1,196.04
1,151.74
1,126.91
1,053.99
Earnings per share (EPS)
0.58
0.42
0.67
0.16
0.15
0.18
0.17
Diluted Earnings per share
0.58
0.42
0.67
0.16
0.15
0.18
0.17
Operating Profit Margin (Excl OI)
13.7%
10.13%
7.98%
8.05%
7.23%
7.62%
8.87%
Gross Profit Margin
21.51%
18.05%
23.79%
11.8%
13.35%
14.86%
14.57%
PAT Margin
14.61%
11.68%
16.21%
4.54%
5.07%
7.36%
7.09%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 9.20% vs -9.31% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 39.09% vs -35.09% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 33.32% vs 6.25% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 2.79% vs -13.31% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Hunan Fangsheng Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,746.51
0
1,746.51
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,746.51
0
1,746.51
Raw Material Cost
548.67
0
548.67
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
22.12
0
22.12
Selling and Distribution Expenses
821.71
0
821.71
Other Expenses
10.10
0.00
10.10
Total Expenditure (Excl Depreciation)
1,493.53
0
1,493.53
Operating Profit (PBDIT) excl Other Income
252.98
0.00
252.98
Other Income
85.30
0
85.30
Operating Profit (PBDIT)
409.35
0
409.35
Interest
22.12
0
22.12
Exceptional Items
-11.52
0
-11.52
Gross Profit (PBDT)
1,197.85
0
1,197.85
Depreciation
84.85
0
84.85
Profit Before Tax
290.86
0
290.86
Tax
36.14
0
36.14
Provisions and contingencies
0
0
0.00
Profit After Tax
255.22
0
255.22
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
255.22
0
255.22
Share in Profit of Associates
0
0
0.00
Minority Interest
-5.37
0
-5.37
Other related items
0.00
0.00
0.00
Consolidated Net Profit
249.85
0
249.85
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,622.97
0
1,622.97
Earnings per share (EPS)
0.58
0
0.58
Diluted Earnings per share
0.58
0
0.58
Operating Profit Margin (Excl OI)
13.70%
0%
0.00
13.70%
Gross Profit Margin
21.51%
0%
0.00
21.51%
PAT Margin
14.61%
0%
0.00
14.61%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 174.65 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 9.20% vs -9.31% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 24.98 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 39.09% vs -35.09% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 32.41 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 33.32% vs 6.25% in Dec 2023

Annual - Interest
Interest 2.21 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 2.79% vs -13.31% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.70%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023